Home/Filings/4/0001062993-22-019774
4//SEC Filing

Farfel Gail M 4

Accession 0001062993-22-019774

CIK 0001374339other

Filed

Sep 19, 8:00 PM ET

Accepted

Sep 20, 4:57 PM ET

Size

5.4 KB

Accession

0001062993-22-019774

Insider Transaction Report

Form 4
Period: 2022-09-19
Farfel Gail M
Chief Executive Officer
Transactions
  • Award

    Option (right to buy)

    2022-09-19+208,334208,334 total
    Exercise: $7.10Exp: 2032-09-19Common Shares (208,334 underlying)
Footnotes (2)
  • [F1]Conversion or exercise price is in Canadian dollars.
  • [F2]The option agreement provides that the option vests 25% on the one year anniversary of grant and the balance vests ratably over 36 months.

Issuer

ProMIS Neurosciences Inc.

CIK 0001374339

Entity typeother

Related Parties

1
  • filerCIK 0001614780

Filing Metadata

Form type
4
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 4:57 PM ET
Size
5.4 KB